Key facts
- It has raised $23.1M; the latest was Accelerator/Incubator in Mar 2025.
- Notable investors include MedTech Innovator, Supernova Invest, BOLD Capital Partners, HCS Capital (Israel), Johnson & Johnson — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Discure Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Discure Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Discure Technologies
Developer of a minimally invasive implant designed to treat degenerative disc disease (DDD). The company develops a minimally invasive implantable bioelectronic device designed to reduce the use of opioids and the need for invasive back surgery by actively controlling the reintroduction of fluid, oxygen and nutrients into the degenerated disc, enabling doctors to eliminate pain and restore the disc's standard functionality.
- Sector
- Healthcare
- HQ
- Petach-Tikva, Israel
- Founded
- 2019
- Employees
- 11
- Website
- discuremd.com/
- Ownership
- Privately Held (backing)
Discure Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Discure Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Discure Technologies in its N-PORT filings yet. We sweep new filings monthly.